PERFORMANCE





Interactive chart displaying fund performance. Javascript is required.

Ex-Date Payable Date Record Date Total Distribution   Return of Capital

Interactive chart displaying fund performance. Javascript is required.

Year Total Distribution  

Holdings

as of 31-Dec-2014

Name Weight (%)
NOVARTIS AG 3.73
ROCHE HOLDING AG 2.73
BAIDU INC 2.69
ANHEUSER-BUSCH INBEV SA/NV 2.64
ROYAL DUTCH SHELL PLC 2.39
IMPERIAL TOBACCO GROUP PLC 2.28
ASTRAZENECA PLC 2.15
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 2.08
QUNAR CAYMAN ISLANDS LTD 1.97
ALIBABA GROUP HOLDING LTD 1.86

Exposure Breakdowns

as of 31-Dec-2014

% of Market Value  

United Kingdom

20.0%

Japan

9.6%

China

8.9%

Switzerland

8.2%

France

5.7%

Canada

5.4%

Cash and Derivatives

4.6%

Hong Kong

3.9%

Ireland

3.7%

Germany

3.7%

as of 31-Dec-2014

% of Market Value  

Europe

52.2%

Emerging Markets

18.4%

Asia Pacific Basin

16.2%

North America

8.6%

Cash and Derivatives

4.6%

as of 31-Dec-2014

% of Market Value  

Financials

22.0%

Consumer Discretionary

17.6%

Health Care

14.2%

Information Technology

12.4%

Industrials

11.0%

Consumer Staples

7.6%

Energy

5.4%

Cash and Derivatives

4.6%

Materials

2.2%

Telecommunications

2.1%

as of 31-Dec-2014

% of Market Value  

Cash and Derivatives

4.6%

Large Cap ->$10bn

68.5%

Mid Cap - $2-$10bn

18.2%

Small Cap -<$2bn

8.7%

KEY FACTS

Size of Fund (Millions)

as of 29-Jan-2015

$832.4 M
Managed Assets  

as of 29-Jan-2015

$832.4 M
Inception Date May 30, 2007
Exchange New York Stock Exchange Inc.
Asset Class Equity
Morningstar Category Foreign Large Blend
Lipper Classification Opt Arbitrage/Opt Strat
CUSIP 092524107

Total Expense Ratio 1.05%
Management Fee 0.95%

Shares Outstanding

as of 29-Jan-2015

109,989,277
Number of Holdings

as of 31-Dec-2014

94
Premium/Discount  

as of 29-Jan-2015

-8.06%
3m Avg Volume

as of 31-Dec-2014

529,150

PORTFOLIO CHARACTERISTICS

Average Market Cap (Millions)  

as of 31-Dec-2014

$66,564.6 M

Distribution Rate  

as of 29-Jan-2015

8.45%

% Overwritten  

as of 31-Dec-2014

41.71
Type of Options   Single Stock

More Products

No recently viewed funds available